Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Department of Health and Human Services
Description
The FDA is offering a grant to support research on reducing risks from nitrosamine impurities in human drugs. The goal is to enhance safety while maintaining access to important medications. The recipient of this grant will also explore how to continue this research in collaboration with industry, non-profits, or academia after the funding ends.
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement.
The proposed work directly supports the U.S. FDA’s stated g…
Source
Grant ID
FOR-FD-24-008
Agency
Department of Health and Human Services
Subcategory/Subagency
Food and Drug Administration
Eligibility
The following categories of applicants are invited to apply:
- Small businesses
- Independent school districts
- City or township governments
- County governments
- State governments
- Special district governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Native American tribal governments (Federally recognized)
- For profit organizations other than small businesses
- Public housing authorities/Indian housing authorities
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Native American tribal organizations (other than Federally recognized tribal governments)
Awards & Funding
Award Ceiling
$350,000
Award Floor
$350,000
Funding Amount
Discretionary
Links
Similar opportunities
- Critical Path Public Private Partnerships Clinical Trials Optional
Department of Health and Human Services
- Collaborations to Enhance Drug Development and Regulatory Science
Department of Health and Human Services
- Center for Research on Complex Generics (U18) Clinical Trials Optional
Department of Health and Human Services
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Department of Health and Human Services
- Animal Food Regulatory Program Alliance
Department of Health and Human Services